Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable

Amy Y Wang, MD, Howie Lawrence Weiner, Margaret Green, Richard A. Larson, MD, Olatoyosi Odenike, MD, Andrew Artz, MD, Lucy A Godley, MD, PhD, Michael J. Thirman, MD, Jane E Churpek, MD, Emily K. Curran, MD, Kristen Pettit, MD, Wendy Stock, MD, Hongtao Liu, MDPhD

Blood (2016) 128 (22): 212.

https://doi.org/10.1182/blood.V128.22.212.212

Published: 2016

Journal Articles

Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)

Andrew Hantel, MD, Niloufer Khan, MD, Richard A. Larson, MD, Lucy A. Godley, MD PhD, Michael J. Thirman, MD, Andrew Artz, MD MS, Olatoyosi Odenike, MD, Hongtao Liu, MDPhD, Jane E. Churpek, MD, Darren King, MD, Elizabeth Rich, MD, Kwang Jin Choi, MD, Randall W. Knoebel, PharmD, BCOP, Wendy Stock, MD

Blood (2015) 126 (23): 2518.

https://doi.org/10.1182/blood.V126.23.2518.2518

Published: 2015

Journal Articles

Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

Yasmin H Karimi, MD, Nitin Jain, MD, Margaret Green, Lucy A Godley, MD, PhD, Howie Lawrence Weiner, Gregory Malnassy, Noreen Fulton, Andrew Artz, MD MS, Hongtao Liu, MDPhD, Michael J. Thirman, MD, Michael Daunov, Richard A. Larson, MD, Wendy Stock, MD, Olatoyosi Odenike, MD

Blood (2015) 126 (23): 3777.

https://doi.org/10.1182/blood.V126.23.3777.3777

Published: 2015

Journal Articles

Haplo-Cord Transplantation Vs Unrelated Donor Stem Cell Transplantation in Patients with AML/MDS Older Than 50

Joanna Rhodes, MD, Koen van Besien, MD, Hongtao Liu, MDPhD, Usama Gergis, MD, Stephanie B. Tsai, MD MA, Sebastian Mayer, MD, Wendy Stock, MD, Richard A. Larson, MD, Tsiporah B. Shore, MD, Olatoyosi Odenike, MD, Roger Pearse, MD PhD, Lucy A Godley, MD PhD, Tomer M Mark, MD MSc, Justin Kline, MD, Michael R. Bishop, MD, Andrew S. Artz, MD MS

Blood (2014) 124 (21): 1235.

https://doi.org/10.1182/blood.V124.21.1235.1235

Published: 2014

Journal Articles

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Houda Alachkar, PharmD, PhD, Poh-Yin Yew, PhD, Rui Yamaguch, Kazuma Kiyotani, Hongtao Liu, MDPhD, Andrew S. Artz, MD MS, Amittha Wickrema, PhD, Koen van Besien, MD, Michael R Bishop, MD, Satoru Miyano, PhD, Wendy Stock, MD, Yusuke Nakamura, MD PhD

Blood (2014) 124 (21): 2503.

https://doi.org/10.1182/blood.V124.21.2503.2503

Published: 2014

NARROW

Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable

Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)

Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

Haplo-Cord Transplantation Vs Unrelated Donor Stem Cell Transplantation in Patients with AML/MDS Older Than 50

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Email alerts

ASH Publications

American Society of Hematology

Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable

Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)

Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

Haplo-Cord Transplantation Vs Unrelated Donor Stem Cell Transplantation in Patients with AML/MDS Older Than 50

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only